Odense C

• ALEXIS Recruiting
  2023-510042-24-01 6 2025-01-30 osteoporosis
• Impact of Angiotensin Receptor Blocker in aortic stenosis Recruiting
  2024-518389-28-00 6 2025-01-30 Aortic stenosis
• Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no … Recruiting
  2024-519186-21-01 6 2025-01-30 Staphylococcus aureus bacteremia
• Prednisone treatment in acute interstitial nephritis (PRAISE) Recruiting
  2024-520299-86-00 6 2025-01-22 Acute interstitial nephritis
• REINFORCE – Reducing infection-related readmissions following cystectomy. Recruiting
  2024-514312-27-00 6 2025-01-07 Bacterial infection
• A study to investigate the safety and efficacy of GSK4532990 compared with placebo in adult participants aged 18 to 65 years with alcohol-re … Recruiting
  2024-511596-15-00 4 2024-12-26 Liver Diseases, Alcoholic
• A study to determine if BHV-7000 is safe in adults with refractory focal onset epilepsy Recruiting
  2023-508813-18-00 4 2024-12-18 Refractory Focal Onset Epilepsy
• A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared … Recruiting
  2023-504022-19-01 5 2024-12-13 Polymyositis or dermatomyositis according to 2017 EULAR / ACR classifi
• Ketamine sedation as neuroprotective agent following out-of-hospital cardiac arrest Recruiting
  2024-515987-29-00 11 2024-12-11 Out-of-hospital cardiac arrest
• Brachial plexus nerve block for closed reduction of distal radius fracture Recruiting
  2024-512191-35-00 6 2024-12-10 Distal radius fracture in need of acute closed reduction
• A study to learn if dapirolizumab pegol works and is safe in people with moderately to severely active systemic lupus erythematosus (SLE) Recruiting
  2023-508191-11-00 5 2024-11-28 Systemic lupus erythematosus (SLE)
• Study of Targeted Therapies for the Treatment of Adult Participants with Moderate to Severe Crohn’s Disease Recruiting
  2024-513009-30-00 4 2024-11-21 Moderate to Severe Crohn’s Disease
• HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t … Recruiting
  2024-514917-36-00 5 2024-11-21 Patients with High Risk Neuroblastoma
• An open-label study to assess reduction of daily asthma medication with tezepelumab in patients 12 to 80 years of age with severe asthma Recruiting
  2024-512113-41-00 5 2024-11-20 Severe Asthma
• Bomedemstat vs Hydroxyurea for Essential Thrombocythemia Recruiting
  2023-505232-36-00 5 2024-11-15 Essential thrombocythemia
• A study to learn more about how well sevabertinib works and how safe it is compared with standard treatment, in participants who have advanc … Recruiting
  2024-511319-91-00 5 2024-10-23 Advanced non-small cell lung cancer with HER2 (ERBB2) mutation
• New Beacon Recruiting
  2024-518419-20-00 4 2024-10-23 BRAF V600E mutated colorectal cancer
• Targeting mTOR with everolimus and/or physical training for preventing postmenopausal bone loss and accelerated skeletal aging. The RapaLoad … Recruiting
  2023-508093-28-00 4 2024-10-20 Healthy
• Beneficial effects of Amiloride on progression of Chronic Kidney Disease: A-CKA Recruiting
  2022-500692-31-00 4 2024-10-10 Chronic kidney disease (CKD)
• Repairing Peri-Anal Fistulas with regenerative cell therapeutics (REP-PAF) Recruiting
  2022-502659-73-01 7 2024-10-09 Crypto-glandular perianal fistula
• FAST TRIAL Recruiting
  2024-515507-18-00 5 2024-10-09 Status epilepticus
• A Study to Evaluate ARV-393 in Adult Participants with Advanced Non-Hodgkin’s Lymphoma Recruiting
  2023-510136-36-00 1 2024-09-27 Advanced Non-Hodgkin’s Lymphoma
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting
  2023-508811-21-00 10 2024-09-25 Refractory Focal Onset Epilepsy
• Local Antibiotics for Women Undergoing Breast Reconstruction Surgery with Implants Recruiting
  2024-517672-38-00 5 2024-09-20 Infection

Showing 145–168 of 457 trials